Research programme: cancer radiopharmaceuticals - ITM Group/Technical University of Munich
Latest Information Update: 30 Oct 2024
Price :
$50 *
At a glance
- Originator ITM Group; Technical University Munich
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer